Clinical Usefulness of Simultaneous Measurement of the Tear Levels of CCL17, CCL24, and IL-16 for the Biomarkers of Allergic Conjunctival Disorders

References

• Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, et al. Japanese guideline for allergic conjunctival diseases. Allergol Int 2011;60:191–203.
   PubMedGoogle Scholar
• Leonardi A. Allergy and allergic mediators in tears. Exp Eye Res 2013;117:106–117.
   PubMed Web of Science ®Google Scholar
• Bacon AS, Ahluwalia P, Irani AM, Schwartz LB, Holgate ST, Church MK, et al. Tear and conjunctival changes during the allergen-induced early- and late-phase responses. J Allergy Clin Immunol 2000;106:948–954.
   PubMed Web of Science ®Google Scholar
• Reyes NJ, Saban DR. T helper subsets in allergic eye disease. Curr Opin Allergy Clin Immunol 2014;14:477–484.
   PubMed Web of Science ®Google Scholar
• Montan PG, van Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol 1996;80:556–560.
   PubMed Web of Science ®Google Scholar
• Montan PG, van Hage-Hamsten M, Zetterström O. Sustained eosinophil cationic protein release into tears after a single high-dose conjunctival allergen challenge. Clin Exp Allergy 1996;26:1125–1130.
   PubMed Web of Science ®Google Scholar
• Shoji J, Kitazawa M, Inada N, Sawa M, Ono T, Kawamura M, et al. Efficacy of tear eosinophil cationic protein level measurement using filter paper for diagnosing allergic conjunctival disorders. Jpn J Ophthalmol 2003;47:64–68.
   PubMed Web of Science ®Google Scholar
• Leonardi A, Jose PJ, Zhan H, Calder VL. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology 2003;110:487–492.
   PubMed Web of Science ®Google Scholar
• Fukagawa K, Nakajima T, Tsubota K, Shimmura S, Saito H, Hirai K. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol 1999;103:1220–1221.
   PubMed Web of Science ®Google Scholar
• Shoji J, Inada N, Sawa M. Evaluation of eotaxin-1, -2, and -3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis. Jpn J Ophthalmol 2009;53:92–99.
   PubMed Web of Science ®Google Scholar
• Uchio E, Ono SY, Ikezawa Z, Ohno S. Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy 2000;30:103–109.
   PubMed Web of Science ®Google Scholar
• Fujishima H, Saito I, Takeuchi T, Tsubota K. Immunological characteristics of patients with vernal keratoconjunctivitis. Jpn J Ophthalmol 2002;46:244–248.
   PubMed Web of Science ®Google Scholar
• Inada N, Ishimori A, Shoji J. CCL20/MIP-3 alpha mRNA expression in the conjunctival epithelium of normal individuals and patients with vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol 2014;252:1977–1984.
   PubMed Web of Science ®Google Scholar
• Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic disease: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004;113:334–340.
   PubMed Web of Science ®Google Scholar
• Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005;60:685–688.
   PubMed Web of Science ®Google Scholar
• Laberge S, Ghaffar O, Boguniewicz M, Center DM, Leung DY, Hamid Q. Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol 1998;102:645–650.
   PubMed Web of Science ®Google Scholar
• Shoji J, Inada N, Sawa M. antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Jpn J Ophthalmol 2006;50:195–204.
   PubMed Web of Science ®Google Scholar
• Leonardi A, Curnow SJ, Zhan H, Calder VL. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy 2006;36:777–784.
   PubMed Web of Science ®Google Scholar
• Shoji J, Inada N, Sawa M. Evaluation of novel scoring system named 5-5-5 exacerbation grading scale for allergic conjunctivitis disease. Allergol Int 2009;58:591–597.
   PubMedGoogle Scholar
• Leonardi A, Borghesan F, Faggian D, Secchi A, Plebani M. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995;50:610–613.
   PubMed Web of Science ®Google Scholar
• Kitaura M, Nakajima T, Imai T, Harada S, Combadiere C, Tiffany HL, et al. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 1996;29:7725–7730.
   Web of Science ®Google Scholar
• Center DM, Kornfeld H, Cruikshank WW. Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996;17:476–481.
   PubMedGoogle Scholar
• Cruikshank WW, Center DM, Nisar N, Wu M, Natke B, Theodore AC, et al. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci USA 1994;91:5109–5113.
   PubMed Web of Science ®Google Scholar
• McFadden C, Morgan R, Rahangdale S, Green D, Yamasaki H, Center D, et al. Preferential migration of T regulatory cells induced by IL-16. J Immunol 2007;179:6439–6445.
   PubMed Web of Science ®Google Scholar
• Trudelle A, El Bassam S, Pinsonneault S, Mazer B, Laberge S. Interleukin-16 inhibits immunoglobulin e production by B lymphocytes. Int Arch Allergy Immunol 2007;143:109–118.
   PubMed Web of Science ®Google Scholar
• Baumann R, Rabaszowski M, Stenin I, Tilgner L, Gaertner-Akerboom M, Scheckenbach K, et al. Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity. Clin Exp Allergy 2013;43:1134–1143.
   PubMed Web of Science ®Google Scholar
• Cruikshank WW, Long A, Tarpy RE, Kornfeld H, Carroll MP, Teran L, et al. Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP 1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am J Respir Cell Mol Biol 1995;13:738–747.
   PubMed Web of Science ®Google Scholar
• Karaki M, Dobashi H, Kobayashi R, Tokuda M, Ishida M, Mori N. Expression of interleukin-16 in allergic rhinitis. Int Arch Allergy Immunol 2005;138:67–72.
   PubMed Web of Science ®Google Scholar
• Pullerits T, Lindén A, Malmhäll C, Lötvall J. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis. Allergy 2001;56:871–877.
   PubMed Web of Science ®Google Scholar
• Akiyama K, Karaki M, Kobayashi R, Dobashi H, Ishida T, Mori N. IL-16 variability and modulation by antiallergic drugs in a murine experimental allergic rhinitis model. Int Arch Allergy Immunol 2009;149:315–322.
   PubMed Web of Science ®Google Scholar
• De Bie JJ, Jonker EH, Henricks PA, Hoevenaars J, Little FF, Cruikshank WW, et al. Exogenous interleukin-16 inhibits antigen-induced airway hyper-reactivity, eosinophilia, and Th2-type cytokine production in mice. Allergy 2002;32:1651–1658.
   Google Scholar